SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-19-002289
Filing Date
2019-02-28
Accepted
2019-02-28 16:53:44
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20181231x10k.htm 10-K 1558133
2 EXHIBIT 10.16 mrtx-20181231xex1016.htm EX-10.16 22171
3 EXHIBIT 10.4 mrtx-20181231xex104.htm EX-10.4 247338
4 EXHIBIT 21.1 exhibit211.htm EX-21.1 3770
5 EXHIBIT 23.1 mrtx-20181231xex231.htm EX-23.1 8310
6 EXHIBIT 31.1 mrtx-20181231xex311.htm EX-31.1 12440
7 EXHIBIT 31.2 mrtx-20181231xex312.htm EX-31.2 13498
8 EXHIBIT 32.1 mrtx-20181231xex321.htm EX-32.1 8211
15 miratiprogramsupdate2719.jpg GRAPHIC 77314
16 mrtx2018cumulativetotalretur.jpg GRAPHIC 49075
  Complete submission text file 0001628280-19-002289.txt   7281886

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mrtx-20181231.xml EX-101.INS 1478358
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20181231.xsd EX-101.SCH 46398
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20181231_cal.xml EX-101.CAL 63670
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20181231_def.xml EX-101.DEF 200982
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20181231_lab.xml EX-101.LAB 625456
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20181231_pre.xml EX-101.PRE 347043
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 19644341
SIC: 2834 Pharmaceutical Preparations